Literature DB >> 25953190

Genome Sequence of a Carbapenem-Resistant Strain of Ralstonia mannitolilytica.

Masato Suzuki1, Hisaaki Nishio2, Kohsuke Asagoe3, Kaneyuki Kida4, Satowa Suzuki5, Mari Matsui5, Keigo Shibayama5.   

Abstract

Ralstonia mannitolilytica, a Gram-negative aerobic bacterium, is an opportunistic human pathogen that is becoming more common in cases of nosocomial infections. We report for the first time the whole-genome sequence analysis of R. mannitolilytica strain MRY14-0246, which carries the intrinsic OXA-443/OXA-22-like and OXA-444/OXA-60-like β-lactamase genes and is resistant to meropenem.
Copyright © 2015 Suzuki et al.

Entities:  

Year:  2015        PMID: 25953190      PMCID: PMC4424306          DOI: 10.1128/genomeA.00405-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Ralstonia mannitolilytica, a Gram-negative aerobic bacterium belonging to the genus Ralstonia, is prevalent in water supplies and is becoming more common in cases of nosocomial infections (1). R. mannitolilytica is closely related to Ralstonia pickettii and had previously been named “Pseudomonas thomasii” and R. pickettii biovar 3/“thomasii” (1, 2). In 2001, R. mannitolilytica was classified as a novel species in the genus Ralstonia, based on 16S rRNA gene sequence analysis (2). R. mannitolilytica is known as an opportunistic human pathogen, possibly associated with cystic fibrosis (3), and the clinical isolates frequently exhibit resistance to imipenem (4). However, little is known about drug resistance and virulence phenotypes of R. mannitolilytica because its genetic basis is uncertain. In this report, we announce the first draft genome sequence of R. mannitolilytica. R. mannitolilytica strain MRY14-0246 was recovered from a patient’s urine in a medical institution in Japan and was resistant to meropenem, according to the MIC determined using the Vitek2 system and an Etest (bioMérieux) and applying the recommended breakpoints described by the CLSI (5). Whole-genome shotgun sequencing of strain MRY14-0246 was performed using the Illumina HiSeq 2500 pyrosequencing platform (500- to 750-bp insert size). Paired-end reads (2 × 150 bp) were assembled de novo using CLC Genomics Workbench version 7.5.1 (Qiagen). The draft genome sequence of strain MRY14-0246 consisted of 48 contigs, yielding total sequences of 4,671,011 bp with N50 contig sizes of 328,267 bp. The mean G+C content was 65.8%. A total of 4,357 coding DNA sequences were annotated by the RAST server version 2.0 (http://rast.nmpdr.org). The 16S rRNA gene sequence of strain MRY14-0246 almost matched that of the R. mannitolilytica type strain LMG 6866T (GenBank accession number AJ270258) (99.8%). Strain MRY14-0246 carried two novel class D β-lactamase gene variants, which we named blaOXA-443 and blaOXA-444 (accession numbers LC030178 and LC030179, respectively). The blaOXA-443 and blaOXA-444 genes in strain MRY14-0246 are encoded in contigs 8_1 and 10_1 (accession numbers BBUP01000016 and BBUP01000018), respectively, both of which are parts of the chromosome with no transposable element, suggesting that these oxacillinase genes are intrinsically species-specific in R. mannitolilytica. R. pickettii produces two resident oxacillinases named OXA-22 and OXA-60 (6, 7). Unlike OXA-22, which is a narrow-spectrum oxacillinase, OXA-60 is an extended-spectrum oxacillinase with carbapenem-hydrolyzing properties (6). The OXA-443 and OXA-444 proteins exhibit close similarities to OXA-22 and OXA-60 (86.0% and 90.3% amino acid identities), respectively, suggesting that OXA-444/OXA-60-like β-lactamase could contribute to carbapenem resistance in strain MRY14-0246. Bacterial pathogens frequently use protein secretion systems to interact with their hosts. The type III secretion system (T3SS) and type VI secretion system (T6SS) are known as major virulence factors of the plant pathogen Ralstonia solanacearum (8, 9). Strain MRY14-0246 does not contain the T3SS gene cluster, whereas the strain contains the T6SS gene cluster and two hcp and four vgrG translocator genes. T6SS delivers effectors into neighboring organisms, including bacteria and hosts, leading to cytotoxicity and cell death of targets (10). Hence, T6SS could be an important virulence determinant in R. mannitolilytica. A more detailed report of strain MRY14-0246 will be included in a future publication.

Nucleotide sequence accession numbers.

The whole-genome shotgun projects of R. mannitolilytica strain MRY14-0246 have been deposited at DDBJ/EMBL/GenBank under the accession number BBUP00000000. The version described in this paper is the first version, BBUP00000000.1.
  9 in total

1.  Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov.

Authors:  T De Baere; S Steyaert; G Wauters; P Des Vos; J Goris; T Coenye; T Suyama; G Verschraegen; M Vaneechoutte
Journal:  Int J Syst Evol Microbiol       Date:  2001-03       Impact factor: 2.747

2.  Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays.

Authors:  Florian Daxboeck; Maria Stadler; Ojan Assadian; Eva Marko; Alexander M Hirschl; Walter Koller
Journal:  J Med Microbiol       Date:  2005-01       Impact factor: 2.472

3.  Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis.

Authors:  Tom Coenye; Theodore Spilker; Rebecca Reik; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  Ralstonia spp.: emerging global opportunistic pathogens.

Authors:  M P Ryan; C C Adley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-21       Impact factor: 3.267

Review 5.  Type VI secretion system effectors: poisons with a purpose.

Authors:  Alistair B Russell; S Brook Peterson; Joseph D Mougous
Journal:  Nat Rev Microbiol       Date:  2014-01-02       Impact factor: 60.633

6.  Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D beta-lactamase from Ralstonia (Pseudomonas) pickettii.

Authors:  P Nordmann; L Poirel; M Kubina; A Casetta; T Naas
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

7.  OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii.

Authors:  Delphine Girlich; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 8.  Opening the Ralstonia solanacearum type III effector tool box: insights into host cell subversion mechanisms.

Authors:  Laurent Deslandes; Stephane Genin
Journal:  Curr Opin Plant Biol       Date:  2014-05-29       Impact factor: 7.834

9.  TssB is essential for virulence and required for type VI secretion system in Ralstonia solanacearum.

Authors:  Liqing Zhang; Jingsheng Xu; Jin Xu; Hao Zhang; Liyuan He; Jie Feng
Journal:  Microb Pathog       Date:  2014-06-24       Impact factor: 3.738

  9 in total
  3 in total

1.  Osteomyelitis Caused by Ralstonia mannitolilytica, a Rare Opportunistic Pathogen.

Authors:  Eftychios Papagrigorakis; Michail Vavourakis; Christos Vlachos; Dimitrios Zachariou; Athanasios Galanis; Vasileios Marougklianis; Vasileios Polyzois; Spiros Pneumaticos
Journal:  Cureus       Date:  2022-04-14

2.  Ralstonia mannitolilytica infections in an oncologic day ward: description of a cluster among high-risk patients.

Authors:  Claudia Lucarelli; Enea Gino Di Domenico; Luigi Toma; Domenico Bracco; Grazia Prignano; Maria Fortunati; Lorella Pelagalli; Fabrizio Ensoli; Patrizio Pezzotti; Aurora García-Fernández; Annalisa Pantosti; Loredana Ingrosso
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-07       Impact factor: 4.887

3.  Longitudinal changes in the nasopharyngeal resistome of South African infants using shotgun metagenomic sequencing.

Authors:  Rendani I Manenzhe; Felix S Dube; Meredith Wright; Katie Lennard; Heather J Zar; Stephanie Mounaud; William C Nierman; Mark P Nicol; Clinton Moodley
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.